| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Comparison of two different methodologies for the detection of hepatitis B virus DNA in plasma
|
Radhakrishnan, Sujatha
|
|
1999
|
35 |
3 |
p. 215-218
4 p.
|
artikel
|
| 2 |
Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridone
|
Jones, Ronald N
|
|
1999
|
35 |
3 |
p. 227-234
8 p.
|
artikel
|
| 3 |
Disk diffusion susceptibility test development for the new glycylcycline, GAR-936
|
Jones, Ronald N
|
|
1999
|
35 |
3 |
p. 249-252
4 p.
|
artikel
|
| 4 |
Enhanced mycobacterium tuberculosis direct test for detection of M. tuberculosis complex in positive ESP II broth cultures of nonrespiratory specimens
|
Bergmann, John S
|
|
1999
|
35 |
3 |
p. 245-248
4 p.
|
artikel
|
| 5 |
Evaluation of Light Diagnostics SimulFluor HSV/VZV Immunofluorescence assay
|
Scicchitano, Lisa M
|
|
1999
|
35 |
3 |
p. 205-208
4 p.
|
artikel
|
| 6 |
HCV seroreactivity and detection of HCV RNA in cirrhotics
|
Berry, Nidhika
|
|
1999
|
35 |
3 |
p. 209-213
5 p.
|
artikel
|
| 7 |
Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia: comparison of data from 1997 and 1998 using the Etest method
|
Pfaller, Michael A
|
|
1999
|
35 |
3 |
p. 235-241
7 p.
|
artikel
|
| 8 |
Novel microtiter plate format for testing germ tube formation and proposal of a cost-effective scheme for yeast identification in a clinical laboratory
|
Peltroche-Llacsahuanga, Heidrun
|
|
1999
|
35 |
3 |
p. 197-204
8 p.
|
artikel
|
| 9 |
Predictive value of a positive nasal swab for Aspergillus SP. in the diagnosis of invasive aspergillosis in adult neutropenic cancer patients
|
Nucci, Marcio
|
|
1999
|
35 |
3 |
p. 193-196
4 p.
|
artikel
|
| 10 |
Profound thrombocytopenia in Plasmodium vivax malaria
|
Kakar, Atul
|
|
1999
|
35 |
3 |
p. 243-244
2 p.
|
artikel
|
| 11 |
Routine use of the gen-probe MTD2 amplification test for detection of Mycobacterium tuberculosis in clinical specimens in a large public health mycobacteriology laboratory1 1 The MTD2 kit “for export,” as used in Canada and this study does not have an indeterminate cut-off value. The recently FDA approved (1998) MTD2 kit for use in the United States, recommends an indeterminate cut-off level of 500,000 RLUs. Our experience with the first MTD1 kit was that some results gave a low amplification of 30,000 to 300,000 RLUs, which were subsequently negative on repeat testing. On discussion wth Gen-Probe Inc., San Diego, in 1997, it was agreed that we would interpret results in the range of 30,000 to 300,000 RLUs as indeterminate.
|
Chedore, Pamela
|
|
1999
|
35 |
3 |
p. 185-191
7 p.
|
artikel
|
| 12 |
Synergistic effect of gentamicin plus ampicillin on enterococci with differing sensitivity to gentamicin:
|
Dressel, Dana C.
|
|
1999
|
35 |
3 |
p. 219-225
7 p.
|
artikel
|
| 13 |
Two-year survey of Alberta laboratories processing of antenatal group B streptococcal (GBS) screening specimens: implications for GBS screening programs
|
Davies, H.Dele
|
|
1999
|
35 |
3 |
p. 169-176
8 p.
|
artikel
|
| 14 |
Use of the paraffin wax baiting system for identification of Pseudomonas aeruginosa clinical isolates
|
Massengale, A.Rene D
|
|
1999
|
35 |
3 |
p. 177-183
7 p.
|
artikel
|
Tijdschrift beschrijving